Search Results

50 results were found

Activity Type CME Provider Title Credit Hours Fee End Date
Reset sort order
JAMA Oncology Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic 1 Yes 11/7/2025
JAMA Oncology Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic 1 Yes 11/7/2025
JAMA Oncology An Atypical Rash on the Chest 1 Yes 12/29/2025
JAMA Oncology A Case of Multiple Hemorrhagic Friable Nodules 1 Yes 1/5/2026
JAMA Oncology Worsening Rash in a Patient With Metastatic Breast Cancer 1 Yes 2/16/2026
JAMA Oncology Left Axilla Adenocarcinoma of Unknown Origin 1 Yes 3/16/2026
JAMA Oncology Nonhealing Cutaneous Ulcers in a Patient With Myelodysplastic Syndrome 1 Yes 4/13/2026
JAMA Oncology Left Shoulder Fungating Mass in a 46-Year-Old Man 1 Yes 6/15/2026
JAMA Oncology Scattered Painful Papulonodules in an Older Woman 1 Yes 7/20/2026
JAMA Oncology Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma - A Review 1 Yes 8/3/2026
JAMA Oncology Immunotherapy in the Treatment of Localized Genitourinary Cancers 1 Yes 8/10/2026
JAMA Oncology Oral Mucosal Pigmentation in a Patient With Mycosis Fungoides 1 Yes 8/10/2026
JAMA Oncology Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer - A Review 1 Yes 9/7/2026
JAMA Oncology Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell Carcinoma - A Narrative Review 1 Yes 10/12/2026
JAMA Oncology A Young Man With a Neck Mass and Hypereosinophilia 1 Yes 10/19/2026
JAMA Oncology Tumor Mutational Burden Testing in Solid Tumors 1 Yes 10/26/2026
JAMA Oncology Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma - A Review 1 Yes 12/14/2026
JAMA Oncology Rapid Advances in Resectable NonSmall Cell Lung Cancer - A Narrative Review 1 Yes 12/28/2026
JAMA Oncology Decentralized Clinical Trials as a New Paradigm of Trial Delivery to Improve Equity of Access 1 Yes 2/15/2027
JAMA Oncology PARP Inhibitors for Breast Cancer Treatment - A Review 1 Yes 3/21/2027